The International Myeloma Working Group Guidelines for the Diagnosis of Multiple Myeloma
The International Myeloma Working Group (IMWG) issued updated guidelines at the end of 2014 for the diagnosis of Multiple Myeloma (MM). One of the most important updates to the guidelines is the incorporation of ‘high-risk’ Monoclonal Gammopathy of Undetermined Significance (MGUS) patients into the ‘active Myeloma’ category.